低钙血症对需输血患儿创伤后死亡率的影响
本研究回顾性查询一家儿童创伤中心2013–2022年数据库,纳入伤后24小时内接受输血且入院时有离子钙(iCal)检测的18岁以下儿童,排除到院前已接受大量输血(>40 mL/kg)或实验室检测前已补钙者,低钙血症定义为iCal<1.00(实验室下限)。共331例,中位年龄7岁(IQR 2-3岁)、中位ISS 25(14-33),32例(10%)入院时低钙。低钙组ISS更高、入院GCS更低;单因素分析低钙与院内死亡(56% vs 18%,p<0.001)和24小时死亡(28% vs 5%,p<0.001)升高相关,24小时体重校正血制品用量中位多22 mL/kg(IQR 7-38,p=0.005)。校正ISS、休克指数、GCS和总输血量后,低钙仍独立与24小时死亡(OR 4.93,95%CI 1.77-13.77,p=0.002)和院内死亡(OR 3.41,95%CI 1.22-9.51,p=0.019)相关。作者认为儿童创伤中及时补钙的获益尚需进一步探索。
要点
- 儿童创伤需输血者入院低钙(iCal<1.00)占10%(32/331),低钙组中位ISS 30(24-36)高于非低钙组22(13-30),入院GCS中位3(3-12)低于8(3-15)。
- 单因素分析低钙与院内死亡(56% vs 18%,p<0.001)和24小时死亡(28% vs 5%,p<0.001)升高相关。
- 低钙组入院后24小时体重校正血制品总量中位多22 mL/kg(IQR 7-38,p=0.005)。
- 校正ISS、休克指数、GCS和总输血量后,低钙独立与24小时死亡(OR 4.93,95%CI 1.77-13.77,p=0.002)和院内死亡(OR 3.41,95%CI 1.22-9.51,p=0.019)相关。
- 作者认为儿童创伤中及时补钙的获益尚需进一步探索。
适用人群与场景
- 一家儿童创伤中心2013–2022年数据库中18岁以下、伤后24小时内接受输血且入院时有离子钙(iCal)检测的儿童。
- 排除到院前已接受大量输血(>40 mL/kg)或实验室检测前已补钙的儿童。
诊断标准与关键阈值
- 低钙血症定义为离子钙低于实验室下限(iCal<1.00)。
研究设计与关键结果
- 回顾性查询一家儿童创伤中心数据库(2013–2022年),共纳入331例,中位年龄7岁(IQR 2-3岁),中位ISS 25(14-33),32例(10%)入院时低钙。
- 低钙组中位ISS 30(24-36)vs 非低钙组22(13-30),入院GCS中位3(3-12)vs 8(3-15);年龄、性别、种族和受伤机制两组无显著差异。
- 单因素分析:低钙与院内死亡(56% vs 18%,p<0.001)和24小时死亡(28% vs 5%,p<0.001)升高相关。
- 低钙组入院后24小时体重校正血制品总量中位多22 mL/kg(IQR 7-38,p=0.005)。
- 校正ISS、休克指数、GCS和总输血量后,低钙独立与24小时死亡(OR 4.93,95%CI 1.77-13.77,p=0.002)和院内死亡(OR 3.41,95%CI 1.22-9.51,p=0.019)相关。
证据类型、等级与局限
- 证据类型:回顾性研究,证据等级:预后与流行病学,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对需输血的创伤患儿,入院iCal<1.00提示24小时和院内死亡风险更高、24小时体重校正血制品用量更大(中位多22 mL/kg),可据此加强监护与输血管理。
- 作者认为,儿童创伤中及时补钙的获益尚需进一步探索。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Admission hypocalcemia has been associated with poor outcomes in injured adults. The impact of hypocalcemia on mortality has not been widely studied in pediatric trauma.
METHODS: A pediatric trauma center database was queried retrospectively (2013-2022) for children younger than 18 years who received blood transfusion within 24 hours of injury and had ionized calcium (iCal) level on admission. Children who received massive transfusion (>40 mL/kg) prior to hospital arrival or calcium prior to laboratory testing were excluded. Hypocalcemia was defined by the laboratory lower limit (iCal <1.00). Main outcomes were in-hospital mortality and 24-hour blood product requirements. Logistic regression analysis was performed to adjust for Injury Severity Score (ISS), admission shock index, Glasgow Coma Scale (GCS) score, and weight-adjusted total transfusion volume.
RESULTS: In total, 331 children with median (IQR) age of 7 years (2-3 years) and median (IQR) ISS 25 (14-33) were included, 32 (10%) of whom were hypocalcemic on arrival to the hospital. The hypocalcemic cohort had higher ISS (median (IQR) 30(24-36) vs. 22 (13-30)) and lower admission GCS score (median (IQR) 3 (3-12) vs. 8 (3-15)). Age, sex, race, and mechanism were not significantly different between groups. On univariate analysis, hypocalcemia was associated with increased in-hospital (56% vs. 18%; p < 0.001) and 24-hour (28% vs. 5%; p < 0.001) mortality. Children who were hypocalcemic received a median (IQR) of 22 mL/kg (7-38) more in total weight-adjusted 24-hour blood product transfusion following admission compared to the normocalcemic cohort ( p = 0.005). After adjusting for ISS, shock index, GCS score, and total transfusion volume, hypocalcemia remained independently associated with increased 24-hour (odds ratio, 4.93; 95% confidence interval, 1.77-13.77; p = 0.002) and in-hospital mortality (odds ratio, 3.41; 95% confidence interval, 1.22-9.51; p = 0.019).
CONCLUSION: Hypocalcemia is independently associated with mortality and receipt of greater weight-adjusted volumes of blood product transfusion after injury in children. The benefit of timely calcium administration in pediatric trauma needs further exploration.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.
参考来源
- Abou Khalil E, Feeney E, Morgan KM, et al. Impact of hypocalcemia on mortality in pediatric trauma patients who require transfusion. J Trauma Acute Care Surg. 2024. PMID: 38587878. doi:10.1097/TA.0000000000004330
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。